Nrg1 haploinsufficiency alters inhibitory cortical circuits

Neurobiol Dis. 2021 Sep:157:105442. doi: 10.1016/j.nbd.2021.105442. Epub 2021 Jul 8.

Abstract

Neuregulin 1 (NRG1) and its receptor ERBB4 are schizophrenia (SZ) risk genes that control the development of both excitatory and inhibitory cortical circuits. Most studies focused on the characterization ErbB4 deficient mice. However, ErbB4 deletion concurrently perturbs the signaling of Nrg1 and Neuregulin 3 (Nrg3), another ligand expressed in the cortex. In addition, NRG1 polymorphisms linked to SZ locate mainly in non-coding regions and they may partially reduce Nrg1 expression. Here, to study the relevance of Nrg1 partial loss-of-function in cortical circuits we characterized a recently developed haploinsufficient mouse model of Nrg1 (Nrg1tm1Lex). These mice display SZ-like behavioral deficits. The cellular and molecular underpinnings of the behavioral deficits in Nrg1tm1Lex mice remain to be established. With multiple approaches including Magnetic Resonance Spectroscopy (MRS), electrophysiology, quantitative imaging and molecular analysis we found that Nrg1 haploinsufficiency impairs the inhibitory cortical circuits. We observed changes in the expression of molecules involved in GABAergic neurotransmission, decreased density of Vglut1 excitatory buttons onto Parvalbumin interneurons and decreased frequency of spontaneous inhibitory postsynaptic currents. Moreover, we found a decreased number of Parvalbumin positive interneurons in the cortex and altered expression of Calretinin. Interestingly, we failed to detect other alterations in excitatory neurons that were previously reported in ErbB4 null mice suggesting that the Nrg1 haploinsufficiency does not entirely phenocopies ErbB4 deletions. Altogether, this study suggests that Nrg1 haploinsufficiency primarily affects the cortical inhibitory circuits in the cortex and provides new insights into the structural and molecular synaptic impairment caused by NRG1 hypofunction in a preclinical model of SZ.

Keywords: Cortical neurons; Inhibitory neurotransmission; Magnetic resonance spectroscopy; Nrg1; Schizophrenia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calbindin 2 / metabolism
  • Cerebral Cortex / diagnostic imaging
  • Cerebral Cortex / metabolism*
  • Cerebral Cortex / pathology
  • Cerebral Cortex / physiopathology
  • GABAergic Neurons / metabolism*
  • GABAergic Neurons / pathology
  • Gene Expression
  • Haploinsufficiency
  • Hippocampus / diagnostic imaging
  • Hippocampus / metabolism*
  • Hippocampus / pathology
  • Hippocampus / physiopathology
  • Inhibitory Postsynaptic Potentials / genetics*
  • Interneurons / metabolism*
  • Interneurons / pathology
  • Magnetic Resonance Imaging
  • Magnetic Resonance Spectroscopy
  • Mice
  • Neural Inhibition / genetics*
  • Neuregulin-1 / genetics*
  • Parvalbumins / metabolism
  • RNA, Messenger / metabolism
  • Receptor, ErbB-4 / genetics
  • Vesicular Glutamate Transport Protein 1 / metabolism*
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Calb2 protein, mouse
  • Calbindin 2
  • Neuregulin-1
  • Nrg1 protein, mouse
  • Parvalbumins
  • RNA, Messenger
  • Slc17a7 protein, mouse
  • Vesicular Glutamate Transport Protein 1
  • gamma-Aminobutyric Acid
  • Erbb4 protein, mouse
  • Receptor, ErbB-4